We aimed to evaluate the imaging findings of hepatic metastases from pancreatic cancers, especially wedgeshaped enhancement and its etiology. Dynamic CT and MR images were performed in 87 patients with liver metastases from pancreatic carcinomas, and CT during arterial portography (CTAP) and CT during hepatic arteriography (CTHA) in 51 patients. Liver metastases were multiple in 84 patients (97%) and solitary in only three (3%). In 44 of 87 patients (51%), all liver metastases showed ring-like enhancement compatible with metastatic adenocarcinomas on dynamic CT and/or dynamic MR imaging. In 37 patients, more than one metastatic lesion showed wedge-shaped contrast enhancement on dynamic CT, dynamic MRI and CTHA, and wedgeshaped perfusion defect on CTAP adjacent to metastatic tumors. Six patients showed multiple wedge-shaped enhancements, which were initially diagnosed as multiple arterioportal shunts (AP shunts). However, metastatic tumors appeared within the area of wedge-shaped enhancement and increased in size on follow-up CT and/ or MR images. After all, 43 of 87 patients (49%) had AP shunt like contrast enhancement adjacent to liver metastases. Liver metastases from pancreatic carcinomas frequently show transient wedge-shaped enhancement, and should not be misdiagnosed as nontumorous arterioportal shunts.
The prognosis of invasive pancreatic carcinoma is quite poor, with an overall median survival time of 8.6 months and a 5-year survival rate of 9.7% [1] . The most important factor in the prognosis of the patients with pancreatic cancers is liver metastasis. If liver metastasis were to be detected by imaging modalities, surgery for pancreatic cancer would not be indicated. In Japan during the past 20 years, 1459 of 9777 (15%) patients initially showed hepatic metastases at the diagnosis of pancreatic carcinoma [1] . Surgery is the only curative treatment for pancreatic carcinoma. However, even if curative resection of the tumor was performed, most patients have a recurrence including higher rate of liver metastases (62%) [2] . High recurrence rate of liver metastases shortly after surgery of pancreatic cancer may imply that liver metastases already exist within the liver at the time of the operation but are too small to be detected by imaging modalities and intraoperative investigation (microscopic metastases) [3] .
CT during arterial portography (CTAP) is considered as a very sensitive imaging modality for preoperative work-up of small liver tumors including metastases [3, 4] . Though CTAP had a high sensitivity of small hepatic lesions, the specificity of CTAP is low due to a high rate of false-positive hepatic lesions (pseudolesions) including laminar flow, aberrant venous drainage, and arterioportal shunt, etc. [5, 6] . Angiography associated CT such as CT during arterial portography (CTAP) combined with CT during hepatic arteriography (CTHA) significant raised the detectability of hepatic tumors and an ability of differentiation between hepatic tumors and nontumorous pseudolesions [7, 8] .
Metastatic adenocarcinomas from gastrointestinal tumors including pancreatic carcinomas usually show ring-like contrast enhancement and delayed contrast enhancement of the central portion of the tumors. We have experienced cases of liver metastases secondary to pancreatic carcinomas which showed wedge-shaped contrast enhancement adjacent the lesions and occasionally we have encountered unexpected cases of liver metastases which have been misdiagnosed as pseudolesions because they initially emerged as arterioportal shunts (AP shunts) on dynamic CT, dynamic MR, and angiography associated CT (CTAP and CTHA). So we retrospectively analyzed CT, MRI, and angiographic CT findings of liver metastases from pancreatic carcinomas especially those of the transient wedge-shaped segmental enhancement associated with metastatic lesions.
Materials and methods

Patients
This study was based on 256 patients with pancreatic carcinomas diagnosed radiologically and/or pathologically from April 1998 and July 2005 in our institution. In 87 patients (48 males and 39 females, aged 43-85 years, mean 67 years), liver metastases were detected by imaging diagnoses (CT, MR, and CT arteriography). Contrast-enhanced CT and contrast-enhanced MR examinations were performed in all patients, whereas abdominal angiography with CT during arterial portography (CTAP) and CT during hepatic arteriography (CTHA) in 51 patients.
CT examinations
CT examinations were performed by helical dynamic CT with a HiSpeed Advantage CT scanner or multidetector row CT with a LightSpeed Ultra 16 (GE Healthcare). Precontrast CT and dynamic contrast enhanced CT were done in all patients. Dynamic CT was scanned 35 s after iodized contrast medium injection (early phase) and 90 s (late phase). The 100-mL of contrast medium was injected at a rate of 3 mL/s with a power injector (Nemoto Kyorindo, Tokyo, Japan). CT images were obtained with 5-mm collimation, pitch of 1.4, and 200 mA for helical CT scanner, and 2.5-mm collimation, pitch 1.5 and 200 mA for MDCT.
MR examinations
MR imaging was performed with a superconducting 1. [8] [9] [10] [11] [12] , 256 · 224 matrix, three acquisitions). The slice thickness was 6 mm with a 2 mm intersection gap for T1-and T2-weighted images. Axial dynamic MR imaging (FMSPGR, 160/1.6/ 90°, 256 · 128 matrix, one acquisition, fat suppression) with breath holding were performed. Dynamic MR imaging with FMSPGR sequence was acquired before and after intravenous administration of gadopentetate dimeglumine (Magnevist, Schering, Berlin). The slice thickness was 6 mm with a 2 mm gap.
Angiographic examinations
In 51 of 87 patients with hepatic metastases from pancreatic carcinomas, abdominal angiography with CT during arterial portography (CTAP) and CT during hepatic arteriography (CTHA) were performed for the detection of hepatic metastases. The combination of CTAP and CTHA was performed on an Xpeed CT scanner (Toshiba Medical, Tokyo, Japan). The CTAP and the CTHA were performed after celiac and superior mesenteric arteriography. For CTAP, 60 mL of iodized contrast material was injected with a power injector through the superior mesenteric artery at a rate of 2 mL/ s, and CT was performed 25 s after the start of the injection. For CTHA, 40 mL of contrast medium was injected through the common hepatic artery at a rate of Early phase of dynamic CT shows multiple ring-like contrast enhancement of the liver compatible with metastatic adenocarcinoma.
1.8 mL/s and the scan was stared 10 s (early phase) and 60 s (late phase) after the start of the injection. The scans were obtained with a 5-mm collimation, pitch 1.4 and 200 mA.
A follow-up dynamic CT of the liver was performed in all the patients during a 2-to 18-month period (mean 6.3 months). A follow-up dynamic MR imaging was also performed in selected cases. In equivocal cases of tumorous and non-tumorous transient wedge-shaped contrast enhancement, we diagnosed as liver metastases if apparent tumorous lesions appeared within the area of transient wedge-shaped contrast enhancement at followup CT and/or MR examinations.
Results
In 87 patients, 84 patients (97%) showed multiple liver metastases and only three patients (3%) revealed solitary liver metastasis. In 44 of 87 patients (51%), all liver metastases showed ring-like contrast enhancement on early phase of dynamic CT (Fig. 1) and MR imaging compatible with metastatic adenocarcinomas. Whereas in 37 patients more than one metastatic lesion revealed wedge-shaped or fan-shaped transient contrast enhancement in the early phase of dynamic CT and dynamic MR imaging adjacent to the metastatic liver tumors (Figs. 2,  3 ). These wedge-shaped areas surrounding the metastatic lesions showed also wedge-shaped portal perfusion defect on CTAP and wedge-shaped contrast enhancement on CTHA. However, six patients showed multiple wedgeshaped contrast enhancement in the early phase of dynamic CT, dynamic MR imaging and CTHA, and multiple wedge-shaped portal perfusion defects which were initially misdiagnosed as nontumorous arterioportal shunts (AP shunts) (Figs. 4, 5) . However, apparent metastatic lesions appeared within the wedge-shaped enhancement and increased in size in follow-up CT and/ or MR images. After all, 43 of 87 patients (49%) had transient wedge-shaped hepatic contrast enhancement mimicking AP shunt adjacent to the liver metastases. Only one patient with solitary liver metastasis from pancreatic head carcinoma associated with wedge-shaped contrast enhancement on dynamic CT and wedge-shaped portal perfusion defect on CTAP underwent hepatic tumor enucleation during pancreaticoduodenectomy. Pathologically, metastatic adenocarcinomas 1.5 cm in diameter showed invasion of the portal tract (GlissonÕs capsule) with tumor thrombi within the peripheral portal venules (Fig. 6 ).
Discussion
Several causes of segmental wedge-shaped transient hepatic contrast enhancement have been considered, including portal vein compression and thrombosis, arterioportal shunt, aberrant venous blood supply, hepatic venous obstruction or thrombosis, hepatic abscess, and intrahepatic cholangitis [9] [10] [11] [12] . The segmental transient hepatic enhancement associated with liver metastases secondary to pancreatic cancer has not been described. In our cases, 84 of 87 patients (97%) showed multiple liver metastases, and 44 of 87 patients (51%) showed peritumoral rim enhancement compatible with adenocarcinoma. In 43 of 87 patients (49%), more than one metastatic lesion was accompanied by wedge-shaped transient hepatic enhancement in the early phase of dynamic studies (dynamic CT, dynamic MRI, and CTHA) and wedge-shaped portal perfusion defect on CTAP. In six patients, we initially misdiagnosed as multiple AP shunts because of multiple wedge-shaped contrast enhancements in the early phase of dynamic studies and portal perfusion defect on CTAP, but follow-up CT showed typical liver metastases within the wedge-shaped contrast enhanced areas.
The etiology of this transient enhancement related with liver metastases from pancreatic cancer is unknown. The reason why liver metastases from pancreatic carcinomas have higher frequency of association with AP shunt like wedge-shaped enhancement than that of other gastrointestinal carcinomas is also unknown. We performed pathological examination of one case of liver metastasis associated with wedge-shaped enhancement on dynamic CT and wedge-shaped portal perfusion defect on CTAP. Pathologically, liver metastasis 1.5 cm in diameter showed invasion of the portal tract with tumor thrombi within the portal venules. We supposed that the etiology of transient hepatic enhancement of liver metastasis from pancreatic carcinomas may be correlated with the tumor invasion of portal tract and tumor thrombi of portal venules which causes decreased portal flow and increased hepatic arterial blood flow.
The characterizing imaging features of liver metastases including ring-like enhancement with transient wedge-shaped enhancement should be differentiated from liver abscesses [11] . Patients with obstructive jaundice due to pancreatic head carcinomas sometimes accompany intrahepatic cholangitis and liver abscesses. Liver abscesses frequently show ring-like contrast enhancement with transient segmental contrast enhancement on early phase of dynamic CT. The etiology of segmental stain was supposed to be that the portal flow decrease and compensatory hepatic arterial flow increase due to the stenosis of portal venules within the portal tract surrounding the hepatic abscesses [11] .
Hepatic abscesses sometimes show double target appearance (three layered structures: central hypodense area indicating abscess cavity, intermediate rim like enhancement indicating abscess wall, and outer hypodense rim indicating secondary edema of surrounding hepatic parenchyma) on the early phase of dynamic CT, and thick ring-like enhancement of the intermediate and outer layer of them on the late phase [12] . Transient segmental contrast enhancement of the hepatic abscesses usually disappear or decrease in size on follow-up dynamic CT after the medication of antibiotic agents. These double target appearance and serial changes of segmental wedge shaped contrast enhancement may a clue to differentiation of hepatic abscesses and hepatic metastases secondary to pancreatic carcinoma.
In our six patients, liver metastases initially emerged as wedge-shaped transient contrast enhancement without definite ring-like contrast enhancement indicating hepatic metastases on CT and MRI, and definite metastatic mass lesions appeared within these transient enhanced areas on follow-up dynamic CT. Differentiation between wedgeshaped enhancement of liver metastasis from pancreatic carcinoma and nontumorous AP shunt may be difficult. Nontumorous AP shunts are frequently associated with liver cirrhosis, wedge-shaped, geographic, and nodular in configuration, and sometime show hyperattenuating liner branching structures that represented early opacification of portal veins in the early phase of dynamic CT. In our six cases of AP shunt like enhancement, early opacification of portal vein branches was not seen. So if portal vein branches were detected within the wedge-shaped enhancement, nontumorous AP shunts would be more likely than tumorous perfusion abnormality.
In patients with pancreatic head carcinoma frequently have obstructive jaundice and occasionally suffered from intrahepatic cholangitis. Intrahepatic cholangitis also shows transient inhomogeneous wedge-shaped enhancement on dynamic CT. The etiology transient wedgeshaped enhancement was thought to be as same as that of hepatic abscess [11, 12] . Transient wedge-shaped hepatic enhancement due to intrahepatic cholangitis is also difficult to differentiate from that of hepatic metastases of pancreatic carcinomas by imaging diagnoses. However, transient hepatic enhancement due to intrahepatic cholangitis also disappear or decrease in size after treatment of cholangitis like hepatic abscesses [12] . So, follow-up dynamic CT or dynamic MRI would be encouraged to differentiate between intrahepatic cholangitis and hepatic metastasis from pancreatic carcinomas.
If the degree of this wedge-shaped contrast enhancement is slight, we would not recognize it itself. In the case of liver metastases emerging as faint wedge-shaped enhancement, angiography associated CT such as CTAP and CTHA depicts hepatic portal and arterial perfusion abnormalities more clearly than dynamic CT and MRI. CTAP and CTHA may be most effective modalities of surveying liver metastases from pancreatic carcinoma, especially emerging as not definite nodular lesions but transient wedge-shaped stain on contrast enhanced CT and MRI.
In conclusion, radiologists should realize that liver metastases from pancreatic carcinomas are frequently associated with transient wedge-shaped contrast enhancement and occasionally, wedge-shaped enhancement is the only radiological finding of lever metastasis, and should not misdiagnose as nontumorous arterioportal shunt.
